EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Phytochemical Nanoparticles for the Treatment of Neurological Disorders

Touraj Ehtezazi iD, Satyajit D Sarker

Phytochemical Analysis · 2025-10 · 36 (7) · 1918-1935

DOI: 10.1002/pca.70020 ↗

At a glance

Übersichtsarbeit in Phytochemical Analysis, published online on 2025-07-29. Written by Touraj Ehtezazi and 1 co-authors. Institution: Centre for Natural Product Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK. Major MEDLINE topics: Phytochemicals, Nanoparticles, Nervous System Diseases, Neurodegenerative Diseases. Cited 11 times so far (Crossref); 190 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Neurological disorders impose a significant burden on the healthcare systems. The latest published data by WHO indicated that stroke was the second leading cause of death globally in 2020, with Alzheimer's disease ( AD ) and other dementias in the seventh position. The treatment of neurological disorders is challenging because of the complex nature of the disease, as well as limited accessibility to this target organ due to several biological barriers. There is a wide range of treatment options for neurological disorders. Small drug molecules, antibodies, and stem cells have been employed for the treatment of neurodegenerative diseases such as AD, but currently, there is no effective treatment for AD. As conventional drugs have not been successful in achieving therapeutic outcomes, natural products such as curcumin, stemming from traditional medicines, have been tested for the treatment of neurodegenerative diseases such as AD. However, this compound has not shown significant therapeutic effects for the treatment of brain diseases, mainly due to rapid clearance from the body. Therefore, phytochemical nanoparticles have been developed. In this review article, the rationale has been provided for the use of nanoparticles for the treatment of neurodegenerative diseases with emphasis on phytochemical nanoparticles.

Subjects

MeSH terms (MEDLINE)

PhytochemicalsNanoparticlesNervous System DiseasesNeurodegenerative DiseasesHumansAnimalsAlzheimer DiseaseCurcumin

Author keywords

Alzheimer's diseaseblood–brain barriernanoparticlesneurological disordersphytochemical

Substances

PhytochemicalsCurcumin

Authors and institutions

  • Centre for Natural Product Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.

ORCID profiles: Touraj Ehtezazi

Cite

APA

Ehtezazi, T., & Sarker, S. D. (2025). Phytochemical Nanoparticles for the Treatment of Neurological Disorders. Phytochemical Analysis, 36(7), 1918-1935. https://doi.org/10.1002/pca.70020

Vancouver

Ehtezazi T, Sarker SD. Phytochemical Nanoparticles for the Treatment of Neurological Disorders. Phytochemical Analysis. 2025;36(7):1918-1935. doi:10.1002/pca.70020

BibTeX
@article{Ehtezazi2025,
  author = {Ehtezazi, Touraj and Sarker, Satyajit D},
  title = {Phytochemical Nanoparticles for the Treatment of Neurological Disorders},
  journal = {Phytochemical Analysis},
  year = {2025},
  volume = {36},
  number = {7},
  pages = {1918--1935},
  doi = {10.1002/pca.70020}
}
Start for free →